Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Monitoring nafcillin therapy, especially in patients in renal failure
Evaluating patient compliance
Nafcillin is used for treatment of infections by gram-positive bacteria
such as Enterococcus faecalis, Staphylococcus species, Streptococcus
pneumonia, and B-hemolytic strains of streptococcus.
Nafcillin has a wide therapeutic index and dose-dependent toxicity.
Accordingly, routine drug monitoring is not indicated in all patients.
Nafcillin accumulates in renal failure patients.
PLASMA OR SERUM
Peak: 1-9 ug/mL
No trough therapeutic range established.
SPINAL FLUID
No established reference values
The antibacterial effect will not be achieved if the blood concentration
is <3 ug/mL. No additional benefit is associated with blood
concentration >9 ug/mL.
No significant cautionary statements
Mandell GL: Principles and Practice of Infectious Diseases. Churchill
Livingston Press, London, 1995

